165 related articles for article (PubMed ID: 3910215)
1. Preclinical antitumor and toxicologic profile of carboplatin.
Rose WC; Schurig JE
Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-19. PubMed ID: 3910215
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies identifying carboplatin as a viable cisplatin alternative.
Harrap KR
Cancer Treat Rev; 1985 Sep; 12 Suppl A():21-33. PubMed ID: 3910219
[TBL] [Abstract][Full Text] [Related]
3. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platinol analogs using the M5076 murine sarcoma.
Rose WC
Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
[TBL] [Abstract][Full Text] [Related]
5. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
van Rongen E; Kal HB; Kuijpers WC; van Berkel AH
Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
[TBL] [Abstract][Full Text] [Related]
6. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
Presnov MA; Konovalova AL
Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
[TBL] [Abstract][Full Text] [Related]
7. Towards an assessment of toxicity in the treatment of ovarian cancer.
Dones L; Wiltshaw E; Birkhead BG; Jackson RR
Cancer Chemother Pharmacol; 1987; 20(3):213-8. PubMed ID: 3315279
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin: a clinical review.
Yarbro CH
Semin Oncol Nurs; 1989 May; 5(2 Suppl 1):63-9. PubMed ID: 2657932
[TBL] [Abstract][Full Text] [Related]
10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
11. Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.
Muggia FM
Semin Oncol; 1989 Apr; 16(2 Suppl 5):7-13. PubMed ID: 2655099
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
Yamaguchi H; Kubota T; Takahara T; Takeuchi T; Furukawa T; Kase S; Josui K; Kodaira S; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
[TBL] [Abstract][Full Text] [Related]
14. The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.
Dible SE; Siddik ZH; Boxall FE; Harrap KR
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):813-8. PubMed ID: 2820745
[TBL] [Abstract][Full Text] [Related]
15. Platinum compounds in children with cancer: toxicity and clinical management.
Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R
Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of platinum complexes in athymic mice with human tumors].
Bukharov IK; Osokina LI; Revazova ES; Moroz LV
Vopr Onkol; 1988; 34(9):1084-7. PubMed ID: 3188435
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin: the clinical spectrum to date.
Canetta R; Rozencweig M; Carter SK
Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
[TBL] [Abstract][Full Text] [Related]
18. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor activity of cisplatin and carboplatin against human tumor xenografts serially transplanted into nude mice--with special reference to gastric carcinomas].
Shimoyama Y; Kubota T; Inoue S; Kuzuoka M; Ohishi T; Oka S; Kikuyama S; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2682-7. PubMed ID: 3307633
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
Hashimura T; Okada K; Yoshida O
Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
